Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H29N3S |
| Molecular Weight | 355.54 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCN1C=C(C2=NC(CN(CC)CC)=CS2)C3=CC=CC=C13
InChI
InChIKey=PCNLLVFKBKMRDB-UHFFFAOYSA-N
InChI=1S/C21H29N3S/c1-4-7-10-13-24-15-19(18-11-8-9-12-20(18)24)21-22-17(16-25-21)14-23(5-2)6-3/h8-9,11-12,15-16H,4-7,10,13-14H2,1-3H3
| Molecular Formula | C21H29N3S |
| Molecular Weight | 355.54 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:24:35 GMT 2023
by
admin
on
Sat Dec 16 10:24:35 GMT 2023
|
| Record UNII |
FSE9R26430
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-PTI-1
Created by
admin on Sat Dec 16 10:24:35 GMT 2023 , Edited by admin on Sat Dec 16 10:24:35 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
124037378
Created by
admin on Sat Dec 16 10:24:35 GMT 2023 , Edited by admin on Sat Dec 16 10:24:35 GMT 2023
|
PRIMARY | |||
|
DTXSID201032545
Created by
admin on Sat Dec 16 10:24:35 GMT 2023 , Edited by admin on Sat Dec 16 10:24:35 GMT 2023
|
PRIMARY | |||
|
FSE9R26430
Created by
admin on Sat Dec 16 10:24:35 GMT 2023 , Edited by admin on Sat Dec 16 10:24:35 GMT 2023
|
PRIMARY | |||
|
PTI-1
Created by
admin on Sat Dec 16 10:24:35 GMT 2023 , Edited by admin on Sat Dec 16 10:24:35 GMT 2023
|
PRIMARY | PTI-1 is an indole-based synthetic cannabinoid. It is one of few synthetic cannabinoids containing a thiazole group and is closely related to PTI-2. These compounds may be viewed as simplified analogues of indole-3-heterocycle compounds originally developed by Organon and subsequently further researched by Merck. | ||
|
1400742-46-2
Created by
admin on Sat Dec 16 10:24:35 GMT 2023 , Edited by admin on Sat Dec 16 10:24:35 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
